• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Medidata

Q/A: Medidata VP Talks Overcoming Financial Barriers to Diversity in Clinical Trials

by Fred Pennic 11/12/2024 Leave a Comment

Medidata VP Talks Overcoming Financial Barriers to Diversity in Clinical Trials

Achieving diversity in clinical trials is crucial for developing effective and safe treatments for all populations. Yet, financial barriers often exclude underrepresented groups from participating, hindering progress towards health equity. This disparity raises critical questions about the accessibility and inclusivity of medical research. In this insightful Q&A, Meghan Harrington, VP of Clinical Trial Financial Management at Medidata, a Dassault Systèmes brand, sheds light on the
Read More

Fortrea, Medidata Form AI Partnership to Increase Diversity in Clinical Trials

by Fred Pennic 11/20/2023 Leave a Comment

Fortrea, Medidata Form AI Partnership to Increase Diversity in Clinical Trials

What You Should Know: - Fortrea, a global contract research organization (CRO), and Medidata, a Dassault Systèmes company specializing in clinical trial solutions, announced an AI-powered partnership to increase diversity in clinical trials. - The collaboration aims to leverage Medidata's AI technology, specifically Medidata AI Intelligent Trials, to increase access to diverse patients in Fortrea-conducted clinical trials. Increase Diversity in Clinical Trails This partnership builds
Read More

Drug Development: Allucent Expands Use of Medidata Clinical Cloud

by Fred Pennic 03/10/2023 Leave a Comment

Medidata

What You Should Know: - Medidata announced that Allucent, a contract research organization (CRO) bringing innovation to biopharma companies, is expanding the global use of Medidata’s Clinical Cloud to advance its end-to-end clinical trial operations offering.   - The agreement expands Allucent’s existing utilization of Medidata technologies. These include Rave EDC, eCOA, RTSM,
Read More

Medidata Expands Sensor Cloud Network

by Jasmine Pennic 10/28/2022 Leave a Comment

Medidata

What You Should Know: - Medidata, a Dassault Systèmes company, and Boehringer Ingelheim, today announced a five-year renewal of their collaboration in the wider area of electronic data capture. The agreement extends the use of Rave EDC for Boehringer Ingelheim's clinical trials worldwide and includes myMedidata, Medidata’s suite of patient-facing technologies focused on enhancing patient centricity and diversity in decentralized clinical trials (DCTs). - The
Read More

Medidata Launches New Clinical Operations Technologies

by Jasmine Pennic 06/27/2022 Leave a Comment

Medidata

What You Should Know: - Today, Medidata, a Dassault Systèmes company, is announcing technology enhancements that address key issues in clinical trial management and oversight. - These enhancements are to Medidata Detect and Rave CTMS (Clinical Trial Management System), which will improve both data oversight and reporting for sponsors and contract research organizations (CROs) in two meaningful ways: how they comprehensively monitor their trial data, and how they
Read More

Labcorp & Medidata to Co-Develop Digital Biomarkers & Expand Decentralized Clinical Trials

by Strategic Partnerships 04/01/2022 Leave a Comment

Medidata Announces Decentralized Clinical Trials Program

What You Should Know: - Medidata, a Dassault Systèmes company, today announced that Labcorp, a leading global life sciences company, has selected Medidata's technology platform to extend their 14-year partnership, the foundation of their initiative to co-develop digital biomarkers and expand the use and functionality of decentralized clinical trials. Labcorp Drug Development has developed its offerings on Medidata technologies, starting with Rave EDC
Read More

Medidata, Parexel Expands Partnership to Enhance Decentralized Clinical Trial Delivery

by Jasmine Pennic 02/04/2022 Leave a Comment

Medidata Announces Decentralized Clinical Trials Program

What You Should Know: - Medidata, a Dassault Systèmes company and Parexel, a global clinical research organization (CRO) focused on development and delivery of innovative new therapies to advance patient health extends their 15-year global strategic partnership. This extension includes gaining access to Medidata’s continued innovations in clinical trial technology solutions with its unified platform, support of decentralized clinical trials (DCTs), the myMedidata patient portal, Sensor
Read More

Rho Selects Medidata’s Decentralized Clinical Trials Capabilities

by Jasmine Pennic 10/05/2021 Leave a Comment

Medidata Announces Decentralized Clinical Trials Program

What You Should Know:  - Today, Medidata, a Dassault Systèmes company, announced that Rho, a full-service contract research organization (CRO) with a proven track record of drug development success, is using Medidata to standardize its clinical trial platform for building out its decentralized clinical trial (DCT) technology offerings. This will enable Rho to provide rapid reporting of cross-domain, cross-study data in decentralized trials, where data collection methods have become more
Read More

Medidata, Labcorp Partner to Expand Decentralized Clinical Trials for Digital Biomarker Discovery

by Jasmine Pennic 09/13/2021 Leave a Comment

Medidata, Labcorp Partner to Expand Decentralized Clinical Trials for Digital Biomarker Discovery

What You Should Know: - Medidata, a Dassault Systèmes company, today announced a first-of-its-kind partnership with Labcorp using the Medidata Sensor Cloud to introduce a new model to advance the use of medical-grade sensors in clinical trials and accelerate biomarker discovery. - As part of the partnership, Medidata will receive and process medical-grade sensor data within drug, vaccine and device trials across Labcorp Drug Development’s clinical trial portfolio,
Read More

Medidata Announces Decentralized Clinical Trials Program

by Jasmine Pennic 06/15/2021 Leave a Comment

Medidata Announces Decentralized Clinical Trials Program

What You Should Know: - Today Medidata, a Dassault Systèmes company, announced the launch of the Medidata Decentralized Clinical Trials (DCT) Program, the most comprehensive set of unified, secure technologies that enable full decentralization across the clinical trial continuum. For the first time ever, drug, vaccine, and medical device developers (sponsors) and contract research organizations (CROs) can take advantage of the only platform offering on the market which combines:  -
Read More

  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Next Page

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Kinetik CEO Sufian Chowdhury on Fighting NEMT Fraud & Waste

Most-Read

2019 MedTech Breakthrough Award Category Winners Announced

MedTech Breakthrough Announces 2025 MedTech Breakthrough Award Winners

WeightWatchers Files for Bankruptcy to Eliminate $1.15B in Debt

WeightWatchers Files for Bankruptcy to Eliminate $1.15B in Debt

KLAS: Epic Dominates 2024 EHR Market Share Amid Focus on Vendor Partnership; Oracle Health Sees Losses Despite Tech Advances

KLAS: Epic Dominates 2024 EHR Market Share Amid Focus on Vendor Partnership; Oracle Health Sees Losses Despite Tech Advances

'Cranky Index' Reveals EHR Alert Frustration Peaks Midweek, Highest Among Admin Staff

‘Cranky Index’ Reveals EHR Alert Frustration Peaks Midweek, Highest Among Admin Staff

Madison Dearborn Partners to Acquire Significant Stake in NextGen Healthcare

Madison Dearborn Partners to Acquire Significant Stake in NextGen Healthcare

Wandercraft Begins Clinical Trials for Physical AI-Powered Personal Exoskeleton

Wandercraft Begins Clinical Trials for Physical AI-Powered Personal Exoskeleton

Chipiron Secures $17M to Transform MRI Access with Portable Scanner

Chipiron Secures $17M to Transform MRI Access with Portable Scanner

Abbott to Integrate FreeStyle Libre Glucose Data with Epic EHR

Abbott to Integrate FreeStyle Libre Glucose Data with Epic EHR

5 Ways New Trump Administration Tariffs Are Impacting U.S. Healthcare Now

5 Ways Trump Administration Tariffs Are Impacting U.S. Healthcare Now

iCAD, GE HealthCare Integrate to Advance Breast Cancer Detection with AI

RadNet to Acquire iCAD for $103M in All-Stock Transaction

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |